2019年11月27日,温州市疾病预防控制中心报告1例国外输入性埃及血吸虫病病例。收集患者的临床资料,取患者尿液、粪便和膀胱病理组织切片进行实验室检测,并开展流行病学调查。结果在患者尿沉渣涂片检出埃及血吸虫虫卵,病理组织切片经鉴定考虑“埃及血吸虫虫卵肉芽肿”,综合患者的临床症状、流行病学史,确诊为尼日利亚感染的输入性埃及血吸虫病病例。给予患者口服吡喹酮治疗60 mg/kg × 2 d疗法治疗后,患者症状好转。服药后1周及1月后对患者尿液进行随访复查,未发现虫卵。此例为温州市首例国外输入性埃及血吸虫病病例。

A case of schistosomiasis haematobia imported from abroad was reported from Wenzhou Municipality Center for Disease Control and Prevention On November 27, 2019. The clinical data of the patient were collected; urine and fecal samples as well as the pathological sections of bladder tissue were subject to laboratory examination; and epidemiological investigation was conducted. Schistosoma haematobium eggs were found in the urine sediment smear, and identified in the pathological tissue sections, which were considered as S. haematobium egg granuloma. These findings, combined with the clinical symptoms and epidemiological history of the patient, confirmed the diagnosis of imported schistosomiasis haematobia from Nigeria. After treatment with an oral dose of 60 mg/kg praziquantel × 2 days, the patient's symptom was improved. Follow-up urine testing at 1 week and 1 month after treatment revealed no presence of eggs. This case was the first imported case of schistosomiasis haematobia in Wenzhou city.